Cboe BZX · FIXXHealthcarePharmaceuticals

Leverage Shares 2X Long FIX Daily ETF (FIXX)

$5.26−5.75%
Close Nov 12, 2026 · split-adjusted
Nov 12, 2026$5.26▼ 61.69% in range
Sep 11, 2026Low $3.87 · High $15.67Nov 12, 2026
What changed · written from our data
As of Nov 12, 2026

Leverage Shares 2X Long FIX Daily ETF closed at $5.26 on Nov 12, down 5.75%, 66.5% below its highest close since Mar 28. Volume of 29.6K shares was 1.87× its 20-day average (above normal).

Split-adjusted performance: -52.3% over one month.

Short interest was 2.8K shares at the Oct 30 settlement, down 45.0% from the prior report (1.0 days to cover).

Market cap—
Revenue · quarter$0.00—
Diluted EPS$-0.26—
P/E · TTM—
Net margin—
Dividend yieldNone
Range since Mar 283.87 – 15.67−66.5% from high
Volume29.6K1.87× 20-day avg
Volatility · 60d—Annualised
Short % of float—1.0 days to cover
Net cash$289.6MCash $289.6M
Next earnings—Not scheduled
Split-adjusted performance
1W +35.8%1M −52.3%3M —6M —YTD —1Y —3Y −71.4%5Y −95.5%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 419 companies (100 = best)

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Industry medians: 6-month return −26.6%, revenue growth +10.0%, net margin −36.2%, P/E 17.1×.

Short interest

Details →
Shares short2.8K−45.0% vs prior
Days to cover1.0Settled Oct 30
% of float—
Short vol. 10d38.1%of daily volume

News about Leverage Shares 2X Long FIX Daily ETF

All news →

No recent articles focused on Leverage Shares 2X Long FIX Daily ETF.

Quick answers

What sector is FIXX in?
Healthcare, in the Pharmaceuticals industry.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology